Drawing upon the discussions and conclusions from the KDIGO Optimal Anemia Management Controversies Conference, this webinar explored new therapies and treatment options relevant to the management of anemia in CKD.

Tilman Drüeke (France)

Ironing Out Anemia Management in CKD
Presented by Jodie Babitt (USA)

What is the Future of ESA Therapy?
Presented by Francesco Locatelli (Italy)

Professor Tilman Drüeke is Emeritus Director of Research of the Kidney, Heart and HIV Team at INSERM UMR 1018, Center for Research in Epidemiology and Population Health (CESP) at Paul-Brousse Hospital, Villejuif/Paris, France.

Dr. Jodie Babitt is an Associate Professor of Medicine at Harvard Medical School and the Director of Translational Research in the Nephrology Division at Massachusetts General Hospital. A practicing clinician double board certified in Internal Medicine and Nephrology, Dr. Babitt is also a National Institutes of Health (NIH)-funded Principal Investigator heading a laboratory focused on understanding the mechanisms regulating systemic iron homeostasis.

Professor Francesco Locatelli is past Director of the Department of Nephrology and Dialysis at Alessandro Manzoni Hospital, Lecco, Italy. Prof. Locatelli is Past President of European Renal Association – European Dialysis and Transplant Association (ERA-EDTA), International Society of Blood Purification (ISBP) and of the Italian Society of Nephrology (SIN).

This webinar was supported by an unrestricted educational grant from Vifor Pharma.